The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 18, Issue 5, 2011, Pages 754-760

  Mika, Piotr ^a   Wilk, Boguslaw ^b   Mika, Anna ^a   Marchewka, Anna ^a   Nizankowski, Rafał ^c  

^a UNIVERSITY OF PHYSICAL EDUCATION   (Poland)

^b MCMASTER UNIVERSITY   (Canada)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atherosclerosis; Exercise; Lipids

Indexed keywords

FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MAXIMAL WALKING TIME; PAIN FREE WALKING TIME; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL; WALKING;

AGED; ANALYSIS OF VARIANCE; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FIBRINOGEN; HEMATOCRIT; HUMANS; INTERMITTENT CLAUDICATION; LIPIDS; MALE; MIDDLE AGED; POLAND; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WALKING;

EID: 80054865141     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/1741826710389421     Document Type: Article

References (31)

1. Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE and Housley E. Blood viscosity, fibrinogen, and activa-tion of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87(6): 1915-1920. (Pubitemid 23165634)
2. Ernst EE and Matrai A. Intermittent claudication, exer-cise, and blood rheology. Circulation 1987; 76(5): 1110-1114. (Pubitemid 17157293)
3. Brevetti G, Schiano V and Chiariello M. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? Atherosclerosis 2008; 197(1): 1-11.
4. Gardner AW and Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. J AmA 1995; 274(12): 975-980.
5. Mika P, Spodaryk K, Cencora A and Mika A. Red blood cell deformability in patients with claudication after pain-free treadmill training. Clin J Sport Med 2006; 16(4): 335-340. (Pubitemid 44126841)
6. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR and Brass EP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol 1996; 81(2): 780-788. (Pubitemid 26303231)
7. Tan KH, Cotterrell D, Sykes K, Sissons GR, De Cossard L and Edwards PR. Exercise training for claudicants: changes in blood flow, cardiorespiratory status, meta-bolic functions, blood rheology and lipid profile. Eur J Vasc Endovasc Surg 2000; 20(1): 72-78. (Pubitemid 30497193)
8. Womack CJ, Sieminski DJ, Katzel LI, Yataco A and Gardner AW. Improved walking economy in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc 1997; 29(10): 1286-1290. (Pubitemid 27441270)
9. Izquierdo-Porrera AM, Gardner AW, Powell CC and Katzel LI. Effects ofexercise rehabilitation on cardiovas-cular risk factors in older patients with peripheral arterial occlusive disease. J Vasc Surg 2000; 31(4): 670-677. (Pubitemid 30214479)
10. Mika P, Spodaryk K, Cencora A, Unnithan VB and Mika A. Experimental model of pain-free treadmill train-ing in patients with claudication. Am J Phys Med Rehabil 2005; 84(10): 756-762. (Pubitemid 41416272)
11. Hiatt WR, Hirsch AT, Regensteiner JG and Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Circulation 1995; 92(3): 614-621.
12. American College of Sports Medicine. Guidelines for exercise testing and prescription, 7th edn. Philadelphia: Williams & Wilkins 2006.
13. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA and Fowkes FG. Inter-society consensus for the management ofperipheral arterial disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67. (Pubitemid 46151680)
14. Kotseva K, Wood D, De BG, De BD, Pyorala K and Keli U. EUROASPIRE III: a survey on the livestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil2009; 16(2): 121-137.
15. Muller-Riemenschneider F, Nocon M and Willich SN. Prevalence of modifiable cardiovascular risk factors in German adolescents. Eur J Cardiovasc Prev Rehabil 2010; 17(2): 204-210.
16. Ekblom-Bak E, Hellenius ML, Ekblom O, Engstrom LM and Ekblom B. Independent associations ofphysical activ-ity and cardiovascular fitness with cardiovascular risk in adults. Eur JCardiovasc Prev Rehabil2010; 17(2): 175-180.
17. Kingwell BA, Tran B, Cameron JD, Jennings GL and Dart AM. Enhanced vasodilation to acetylcholine in ath-letes is associated with lower plasma cholesterol. Am J Physiol 1996; 270(6Pt2): H2008-H2013.
18. Singh IM, Shishehbor MH and Ansell BJ. High-density lipoprotein as a therapeutic target: a systematic review. J AmA 2007; 298(7): 786-798. (Pubitemid 47263161)
19. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL and Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998; 339(1): 12-20. (Pubitemid 28304492)
20. Leon AS and Sanchez O. Meta-analysis of the effects of aerobic exercise training on blood lipids. Circulation 2001; 104(suppl II): II414-II415.
21. King AC, Haskell WL, Young DR, Oka RK and Stefanick ML. Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years. Circulation 1995; 91(10): 2596-2604.
22. Pancera P, Prior M, Zannoni M, Lucchese L, De Marchi S and Arosio E. Micro- and macrocirculatory, and biohumoral changes after a month of physical exercise in patients with intermittent claudication. Scand J Rehabil Med 1995; 27(2): 73-76.
23. Tran ZV and Weltman A. Differential effects of exercise on serum lipid and lipoprotein levels seen with changes in body weight. A meta-analysis. J AmA 1985; 254(7): 919-924. (Pubitemid 15045210)
24. Blann A, Bignell A and Mc Collum C. Von Willebrand factor, fibrinogen and other plasma proteins as determi-nants of plasma viscosity. Atherosclerosis 1998; 139(2): 317-322. (Pubitemid 28361816)
25. De FM, Gallo P and Masotti G. Current therapy of peripheral obstructive arterial disease. The non-surgical approach. Angiology 1990; 41(1): 1-11. (Pubitemid 20067111)
26. Doweik L, Maca T, Schillinger M, Budinsky A, Sabeti S and Minar E. Fibrinogen predicts mortality in high risk patients with peripheral artery disease. Eur J Vasc Endovasc Surg 2003; 26(4): 381-386. (Pubitemid 37266146)
27. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population. Circulation 2000; 102(14): 1634-1638.
28. Paraskevas KI, Baker DM, Vrentzos GE and Mikhailidis DP. The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thromb Res 2008; 122(1): 1-12. (Pubitemid 351618332)
29. Tisi PV, Hulse M, Chulakadabba A, Gosling P and Shearman CP. Exercise training for intermittent claudi-cation: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997; 14(5): 344-350. (Pubitemid 27511417)
30. Andreozzi GM, Leone A, Laudani R, Deinite G and Martini R. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermit-tent claudication, and its improvement after supervised physical training. Int Angiol 2007; 26(1): 1217.
31. Mustonen P, Lepantalo M and Lassila R. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18(2): 244-249. (Pubitemid 28277601)